These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 547147)

  • 1. [Treatment of hepatic steatosis in diabetic patients with stanozolol].
    Muxi F; Portos M; Reissenweber N; Turturiello H; Arbes I; Roca R; Manzano O
    Medicina (B Aires); 1979; 39(5):568-74. PubMed ID: 547147
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical associations with hepatic steatosis: a retrospective study.
    Samarasinghe D; Tasman-Jones C
    N Z Med J; 1992 Feb; 105(928):57-8. PubMed ID: 1542474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diabetic metabolic disorders in patients with cholelithiasis].
    Schmauss AK; Weinberger I; Poley F
    Munch Med Wochenschr; 1970 Jul; 112(27):1297-302. PubMed ID: 5467941
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of coenzyme A and adenosine triphosphate on fatty liver in diabetic metabolism].
    Iwamura K
    Z Gastroenterol; 1973 Mar; 11(2):65-74. PubMed ID: 4803411
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relationships between diabetes mellitus and fatty liver].
    Beringer A; Thaler H
    Dtsch Med Wochenschr; 1970 Apr; 95(15):836-8. PubMed ID: 5439535
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatty liver in diabetes. A cytological study.
    Wasastjerna C; Reissell P; Karjalainen J; Ekelund P
    Acta Med Scand; 1972 Mar; 191(3):225-8. PubMed ID: 4113671
    [No Abstract]   [Full Text] [Related]  

  • 7. [The antisteatosic activity of 2-MPG (Thiola). Study with the (BSF) dynamic test and with liver biopsy before and after the treatment].
    Surrenti C; Arcangeli A; Casini A
    Minerva Med; 1978 Dec; 69(61):4251-6. PubMed ID: 733081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.
    Wong VW; Hui AY; Tsang SW; Chan JL; Wong GL; Chan AW; So WY; Cheng AY; Tong PC; Chan FK; Sung JJ; Chan HL
    Aliment Pharmacol Ther; 2006 Oct; 24(8):1215-22. PubMed ID: 17014580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind trial of intramuscular stanozolol in the prevention of postoperative deep vein thrombosis following elective abdominal surgery.
    Blamey SL; McArdle BM; Burns P; Carter DC; Lowe GD; Forbes CD
    Thromb Haemost; 1984 Feb; 51(1):71-4. PubMed ID: 6539002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients.
    Turlin B; Mendler MH; Moirand R; Guyader D; Guillygomarc'h A; Deugnier Y
    Am J Clin Pathol; 2001 Aug; 116(2):263-70. PubMed ID: 11488074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan.
    Hsieh MH; Lee LP; Hsieh MY; Tsai KB; Huang JF; Hou NJ; Chen SC; Lin ZY; Hsieh MY; Wang LY; Dai CY; Chuang WL; Yu ML
    Jpn J Infect Dis; 2007 Nov; 60(6):377-81. PubMed ID: 18032828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early diabetic metabolism anomalies and bioptically objectified degree of fatty degeneration of the liver in biliary calculi patients].
    Kremer GJ; Knick B; Lange HJ; Kössling FK; Grams H
    Schweiz Med Wochenschr; 1968 Jan; 98(4):110-4. PubMed ID: 5670493
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
    Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
    J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
    Angulo P; Keach JC; Batts KP; Lindor KD
    Hepatology; 1999 Dec; 30(6):1356-62. PubMed ID: 10573511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus.
    Falchuk KR; Fiske SC; Haggitt RC; Federman M; Trey C
    Gastroenterology; 1980 Mar; 78(3):535-41. PubMed ID: 6153166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies.
    Papadia FS; Marinari GM; Camerini G; Murelli F; Carlini F; Stabilini C; Scopinaro N
    Obes Surg; 2004 Aug; 14(7):952-8. PubMed ID: 15329185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-statistical correlation studies on manifestations of arteriosclerosis, a latent diabetic situation and fatty liver parenchyma].
    Rother F; Schott H; Knick B; Lange HJ; Fallen H
    Verh Dtsch Ges Inn Med; 1965; 71():757-62. PubMed ID: 5877700
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatic steatosis in aged diabetics].
    Zrůstová M; Rostlapil J
    Acta Univ Carol Med (Praha); 1966; 12(6):405-9. PubMed ID: 6003750
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes.
    Toledo FG; Sniderman AD; Kelley DE
    Diabetes Care; 2006 Aug; 29(8):1845-50. PubMed ID: 16873790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response.
    Kumar D; Farrell GC; Fung C; George J
    Hepatology; 2002 Nov; 36(5):1266-72. PubMed ID: 12395339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.